View AIDSinfo Patient Fact Sheets on Three Recently Approved HIV Medications

AIDSinfo invites you to view our patient fact sheets on three medications recently approved by the FDA. The three medications are all indicated for use in the treatment of HIV infection in adults. The patient fact sheets include information on dosage forms and strengths, possible side effects, and instructions on how to take and store the medications. Fact sheet on abacavir/dolutegravir/lamivudine (brand name: Triumeq) Triumeq is a combination medicine that can be used alone as a complete treatment regimen or with other HIV medicines. Fact sheet on cobicistat (brand name: Tybost) Cobicistat is a pharmacokinetic enhancer indicated for use with atazanavir (brand name: Reyataz) or darunavir (brand name: Prezista) to increase the amount of those medicines in the blood; it must be used in combination with other HIV medicines as well.  Fact sheet on elvitegravir (brand name: Vitekta) Elvitegravir is an integrase inhibitor approved to treat HIV infection in adults who are already taking or have previously taken HIV medicines. Elvitegravir must be used in combination with an HIV protease inhibitor coadministered with ritonavir (brand name: Norvir) and another HIV medicine. Visit the Drugs section of the AIDSinfo website to view the fact sheets and FDA labels for the three medications.